Many unsolved practical issues, from technical and scientific to ethical, legal and economic topics, are slowing down the translation of Personalized Medicine principles into medical practice. The Italian Society of Personalized Medicine exposes here its point of view, based on the real-world practice of precision medicine carried-out in Italian healthcare structures.
H2020 and beyond: skip discrepancy between theory and practice of personalized medicine. A position paper by the italian society of personalized medicine / Borro, Marina; Simmaco, Maurizio; Aceti, Antonio; Barni, Sandro; De Luca, Assunta; Fineschi, Vittorio; Frati, Paola; Girardi, Paolo; Miozzo, Monica; Nati, Giulio; Nicoletti, Ferdinando; Santini, Daniele; Marchetti, Paolo. - In: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. - ISSN 1873-4316. - STAMPA. - 17:10(2016), pp. 926-929. [10.2174/1389201017666160519112850]
H2020 and beyond: skip discrepancy between theory and practice of personalized medicine. A position paper by the italian society of personalized medicine
BORRO, Marina;SIMMACO, Maurizio;ACETI, Antonio;FINESCHI, VITTORIO;FRATI, PAOLA;GIRARDI, Paolo;NICOLETTI, Ferdinando;Santini, Daniele;MARCHETTI, PAOLO
2016
Abstract
Many unsolved practical issues, from technical and scientific to ethical, legal and economic topics, are slowing down the translation of Personalized Medicine principles into medical practice. The Italian Society of Personalized Medicine exposes here its point of view, based on the real-world practice of precision medicine carried-out in Italian healthcare structures.| File | Dimensione | Formato | |
|---|---|---|---|
|
Borro_H2020_2016.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
202.01 kB
Formato
Adobe PDF
|
202.01 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
